• Profile
Close

Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies

Journal of the American Academy of Dermatology Sep 01, 2021

Seiler JC, Keech RC, Aker JL, et al. - Combined results from 2 controlled clinical studies suggest superiority of 0.9% spinosad topical suspension in the eradication of scabies in patients of 4 years of age or older when compared with applying a vehicle.

  • The studies involved index individuals (the youngest household members with active scabies) and up to 5 other members in each household.

  • 0.9% Spinosad or vehicle was applied once.

  • Treatment effect of 0.9% spinosad was consistently evident.

  • There were no safety signals.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay